Amy is a Radio Reporter for QUEST. Amy was born and raised in San Francisco, and received a B.A. in Latin American Studies from Vassar College. Back before the Internet, she became hooked on radio while traveling through India with only a shortwave and the BBC for connection to the outside world. After returning to the States, she learned to cut tape interning for a Latin American news show at WBAI in New York, before taking her first radio job as a producer for Pulse of the Planet. Since then, Amy has been an editor at Salon.com, the editor of Terrain Magazine, and has produced for All Things Considered, Weekend Edition, Living on Earth, Philosophy Talk, and other shows. She's also a founding editor of Meatpaper Magazine.
This story marks the first time I've had to use a pseudynm to protect the identity of a horse.
"Disney's" owner's desire for privacy only underscores the stakes here. Performance horses at his level can be worth $60,000 and more. Training, too, is an enormous investment. "Gretchen," as we call her in the piece, has spent years training Disney in English dressage (which, incidentally, makes for some very entertaining YouTube viewing if you have some time to kill). And so when she noticed that her horse's gait had started to suffer, she jumped to find a treatment.
Speed is key here, it was explained to me, because the smaller the injury, the better a horse's chance for recovery. Emphasizing that point is one of the main reasons Gretchen agreed to take part in this program. She says too many owners treat their horses' injuries with ever-greater doses of painkillers, delaying real treatment until it's too late. Gretchen estimated that, including all the preliminary visits and tests, Disney's treatment may reach $7,000.
Davis vets couldn't provide statistics on whether this treatment - injecting a horse's mesenchymal stem cells, drawn from the marrow of the animal's sternum, into the same animal's torn tendon - succeeds in producing new tendon tissue. (Part of the problem is that it's hard to distinguish tendon tissue from scar tissue, seen through an ultrasound.) But if it works, they believe humans may one day have another option for treating our torn ligaments, too.
As this radio story airs, Congress is debating two Cash for Clunkers proposals, one from the Senate and one from the House of Representatives. (A third proposal, also from the Senate, is almost identical to the House version.) Both would pay consumers to scrap their "clunkers" in exchange for brand-new, more fuel-efficient models. Both define "clunker" as a car that gets less than 18 miles per gallon. But after that, they diverge.
The House version comes from Democrats on the House Committee on Energy and Commerce. If it passes, a consumer would get a $3,500 voucher for trading in a truck with 15 miles per gallon in exchange for buying a new truck that gets 16 miles per gallon - a one MPG difference. (If the new truck got 17 miles a gallon, the consumer would earn $4,500). That's why environmentalists complain that the legislation is more about stimulating car sales than it is about getting gas guzzlers off the road.
The Senate versionproposed by U.S. Senators Dianne Feinstein (D-Calif.), Susan Collins (R-Maine), and Charles Schumer (D-N.Y.), puts the bar a bit higher. In order to qualify for the $3,500 voucher, that same replacement truck would have to get 20 MPG - five miles per gallon more than the old truck. (An improvement of seven miles per gallon would earn the consumer a $4,500 voucher.)
Interestingly, this is a compromise even for Senator Feinstein herself. Check out her original, more stringent, Cash for Clunkers bill here. Proposed in January, it required stricter efficiency from the replacement vehicle, and would have allowed consumers to use their vouchers for used cars, or for public transit. Those conditions were junked, presumably, because they don't stimulate new car sales.
This article from the Christian Science Monitor, takes the number crunching even farther. Among the details worth considering is the "carbon cost" of making all these new vehicles that consumers will be enouraged to buy, should C4C pass: between 3.5 to 12.4 tons of CO2 per vehicle, according to a Duke economist.
For these notes, I thought I'd focus on something that didn’t make it into the sea lions radio broadcast: the necropsy.
Each year the Marine Mammal Center treats somewhere between 600-1000 animals, including California sea lions, Pacific harbor seals, Northern elephant seals, and steller sea lions. About half of them are treated successfully at the center and released into the Pacific. The other half either die naturally or have to be euthanized.
Most of them end up at the center's hospital after passersby spot the animals on the beach and sense something’s wrong. (The Marine Mammal center responds to calls anywhere between Mendocino and San Louis Obispo Counties — some 600 miles of coastline.) Some problems are human-caused, like boat-propeller injuries or ingested fishing nets and hooks. Other times, it's cancer, domoic acid poisoning, or leptospirosis. Sometimes, it's hard to tell exactly what happened — hence the need for necropsies.
On the day that Quest intern Jennifer Skene and I visited the center, veterinarian Nicola Pussini performed two necropsies, both on sea lions. One animal seemed to have died from a tumor underneath his fin; the other was a suspected domoic acid intoxication.
Each necropsy takes about an hour and a half. First Pussini measures the animal, then he slices it open and inspects every part, from tongue to tail. He inspects the teeth, pulls out all the organs, checks to see how much fat the animal has. The data, along with tissue samples, are archived and shared with other research institutions. This is the kind of basic research that Marine Mammal Center staff cite when people ask why they devote so many resources (most of it from private donations) to animals whose populations are neither threatened nor endangered.
I should mention that I didn't exactly see this entire process firsthand. Let's just say that after my first strong whiff of sea lion intestine, I felt a compelling need to go check on things outside the necropsy room. Luckily for me, Jennifer has the stomach of a true scientist and managed to both hold the microphone and take photos. Luckily for you, we’re sparing you her gorier shots.
For those following the controversy (background: Oysters on the Outs, Sep 28, 2007) – and few Marin County land use issues have ignited local passions the way this one has – the report may seem to settle some scores.
Speaking to KQED Public Radio, the study’s lead scientist, Charles Peterson, said "We evaluated all the science in Drakes Estero… and from that concluded that there is no major impact of the Drakes Estero mariculture on the ecosystem of Drakes Estero."
This is contrary to initial findings from the National Park Service, which had sought to shut down the longstanding oyster operation. According to the Park Service, oysters, a non-native species, coat the bay floor in feces and harm other, native wildlife such as eelgrass and harbor seals. After protests from the oyster company and many of its neighbors, the Park Service and Senator Diane Feinstein tapped the National Research Council to take an independent look.
Now, it's up to the Park Service to decide how to react to the NRC's study.
Swine flu is largely untreatable: The two effective antiviral drugs, Tamiflu and Relenza, must be taken within 48 hours of infection to stop the spread of the virus.
That leaves a vaccine. Vaccines are relatively straightforward to create, but they take time. If swine flu becomes a deadly pandemic (meaning it's not only widespread — a pandemic – but more lethal than it appears to be so far) the demand for vaccines would likely far outpace supply. According to Art Reingold, at UC Berkeley's School of Public Health, it could take years for doses to reach everyone in the world who's vulnerable to the disease. Here in the US, we have very few vaccine producing facilities, which means we'd be competing with other countries' priorities to treat their own citizens.
Our story focuses on what could, one day, be the answer to pandemics like this one: a universal vaccine. Scientists like Harvard Medical School's Wayne Marasco believe that, in just a few years, we might be able to inoculate ourselves against nearly all influenza viruses – like a tetanus shot, against the flu. Universal vaccines will come too late for our current swine flu pandemic. But they may well be our response to pandemics of the future.
Since people seem to nod off a bit when I say I'm working on a story about energy efficiency, I've had to re-tool my pitch. "It's a story about how installing solar panels or a wind turbine is the last thing you should do to green your house," I say, perhaps a little over-dramatically.
I have nothing against solar panels, but they do seem to illustrate our collective love of gadgetry. Why else would we leap (or at least dream of leaping) to spend $5,000-$10,000 on solar panels when many of us could make a significant dent in our utility bills with a trip to Home Depot? Small things, like weather-stripping your doors, or making sure you have a well-insulated attic, can make a big difference in how much heat or AC your house consumes.
WAP won't replace your TV, but you might consider doing so yourself. Televisions tend to be the third biggest electricity user in the house (after heating/AC and refrigerators). But they don't have to be. All the new features — plasma screens, HD, widescreen — can be (and are, in some models) achieved using less electricity. The California Energy Commission is proposing new TV standards that would cut electricity use by a third.
James Sweeney, who heads the Stanford University Precourt Energy Efficiency Center, calculates that collectively – with current, affordable technologies, and without sacrificing our quality of life – Americans could cut our energy use by 30 percent.
Here's the kicker: To produce that same amount of electricity, we'd have to increase solar and wind by 60-fold. That means, for every solar panel and wind turbine in the country, we'd have to build 59 new ones, plus all the power lines and roads they'd entail. Or, to consider another non-fossil fuels alternative, that's four new nuclear power plants for every existing one.
Inside the Bevatron. Credit: Lawrence Berkeley National Lab.
Much as I tried to get Stewart Loken to wax poetic about the demise of the Bevatron, the truth is that he – and, I'll bet, a lot of scientists – just don't think that way.
As Loken put it, "science never stands still." However many Nobel prizes the Bevatron produced, this old, defunct particle accelerator is really just taking up space; its demolition, and replacement with a new, up-to-the-minute research facility, is, Loken feels, the best way to honor the work done here. Plans aren't finalized, but it's likely the facility to replace the Bevatron will forward work done at Lawrence Berkeley National Lab's Advanced Light Source (which, by the way, produces light a billion times brighter than the sun).
The new facility – described here – would allow scientists to watch "electrons joining forces, atoms snapping together within millionths of a billionth of a second, the real time of chemical reactions."
But that's a long way off. First, demolition workers must contend with a major disposal challenge, including getting rid of radioactive waste produced during experiments at the Bevatron. Some neighbors are concerned about the prospect of hauling the stuff through Berkeley's residential areas. Others have called for the Bevatron to be preserved as a national landmark.
Scientists gather samples on the ocean floor.
Credit: Roger Linington.There's nothing new about looking to nature to cure disease – we've been doing it for thousands of years, with good results. (Two recent examples: The active ingredient in aspirin was first identified in the bark of the willow tree. And we have the Pacific yew tree to thank for one of the strongest anti-cancer drugs out there, Taxol.)
What's different about the work being done at the UC Santa Cruz Chemical Screening Center is that it a) looks to a largely unexplored medical resource: the ocean, and b) uses robots, rather than "forlorn-looking grad students" (to quote Center director Scott Lokey) to run the tests.
Here's a video I shot of one of those robots in action, with Lokey narrating.
One thing that didn't make it into the piece is that these researchers — including Lokey and Roger Linington — aren't just studying every disease they can think of. They focus on the diseases that commercial drug companies tend to neglect because there's so little profit in treating them – things like African sleeping sickness and cholera. So far, they're seeing progress on both, as well as breast cancer.
You'd have to be a real gas pump aficionado to notice the new gear that gas stations across California are required to have installed by April 1st. California's gas nozzles have been outfitted for some time with vapor-capture devices, designed to cut back on the amount of volatile organic compounds – those smelly fumes - that escape when you pump gas. This explains that accordion-style rubber sheath that bunches up against your gas tank when you pump – a feature you don't necessarily find in states with less stringent air quality laws.
When those fumes combine with sunlight, along with other emissions, they form ground-level ozone, an air pollutant which acts as a greenhouse gas, contributing to global warming much like carbon dioxide does.
Take a look at this nifty, infra-red video footage from the California Air Resources Board, showing how fumes disperse from the gas pump when they aren't properly collected.
Ground-level ozone is also a real problem for human health, especially for people with asthma and respiratory disease. Just this week, UC Berkeley released a study finding that people living in areas with high ozone levels, like Los Angeles and the Central Valley, have a 25-30% greater risk of dying from respiratory disease than those in less ozone-heavy parts of the state, like San Francisco.
By the way, if you're wondering what "ground-level ozone" has to do with that ozone hole we used to hear so much about, here's the short answer: Turns out ozone does different things, depending on where you find it. In the atmosphere, ozone's a good thing. It forms a protective layer that shields the Earth from the sun's radiation – a layer that's been steadily eroded by chlorofluorocarbons, found in aerosol sprays and other places. Here at ground level, ozone's much less likable: a toxic air pollutant, as I said above.
If every station in California installs the new, hi-tech "enhanced vapor recovery system" they'll collectively cut back statewide, ground-level ozone emissions by ten tons a day – that's roughly equivalent to taking 450,000 cars off the road, according to CARB.
We put this story on the calendar back in September, before melamine-tainted milk started making headlines in China (with some products turning up on Asian grocery store shelves here in the US. Find KQED reporter Oanh Ha's excellent reporting on that story here, here, and here). We'd been planning to focus on criticism of FDA's handling of imported fresh produce, and had to recast the piece when it became clear that the concerns around food safety were much broader.
Another plan was shelved when the FDA declined to let us visit any of their local facilities, including a testing lab in Alameda that had been scheduled for closure only a year ago – right around the time that Mexican jalapeno peppers sickened 13,000 people and devastated the domestic tomato industry. (Officials blamed tomatoes before narrowing in on the peppers.) Luckily, the press office from the Bureau of Customs and Border Patrol generously agreed to show us around a Port of Oakland warehouse, where –- I quickly discovered — there were no FDA inspectors to be found. That's because FDA inspectors do their Port work largely in front of computer screens, scanning shipping manifests for products they believe warrant physical inspection.
That means two things: One, the FDA relies largely on the exporters' own description of what's in the product. As several people told me, it's an "honor system." Two, almost none (less than one percent) of the imported produce is ever tested for salmonella, e.coli, or any of the other human health threats we worry about.
When we finally talked to FDA Director of Food Safety David Acheson by phone from Maryland, he made the point pretty clearly: FDA knows its food safety program needs work. But that's going to require more and sustained funding. It'll be interesting to see how well the agency can make that case come January.
The QUEST Community Science Blog explores local science, nature, and environment issues & experiences in Northern California. A collaborative effort, our many writers come from local museums, zoos, science centers and research institutions, as well as KQED's TV and Radio producers covering stories in the field.
Listen to the Stem Cells and Horses radio report online, and watch our Web Extra Slideshow.
2 Comments 
